Preface
Information concerning parasite genomes will be fundamental to the future directions of parasitology research in the new millennium. Already the complete sequences of numerous pathogenic bacteria are available to the scientific community. These sequences contain essential information and clues on drug targets and vaccine candidates and will eventually help to unravel the mechanisms whereby pathogens succeed in their often complex and intricate life cycles. The void between a complete genome sequence of a pathogenic organism and the tools for its control might be truly enormous but the sequence provides the essential foundation for future study. Considerable progress has been made over the last five years to transfer genome technologies to eukaryotic pathogens and it was timely for the British Society for Parasitology to consider parasite genome research at the Autumn Symposium in September 1998. The meeting provided the opportunity to consider the rapid progress being made in various parasite genome projects, bioinformatics of genome analysis (including availability and access) and the exciting possibilities for research in the postgenomic era.
Parasite genome research is neither easy nor straightforward. Parasite genomes vary widely in size and ease of analysis. Some parasite genomes such as those of Schistosoma (170 MB) are far too large to contemplate complete genome sequencing at present, others such as Trypanosoma show surprising plasticity in relation to their chromosomes, whereas the AT-rich genome of Plasmodium means that large fragments are generally unstable in E. coli. In addition, the complex life styles of parasites often restrict the availability of experimental material but pose interesting questions in relation to development and gene expression. In 1995 the World Health Organization launched genome projects for three protozoa and two helminth parasites which formed a useful addition to the ongoing work on Plasmodium falciparum. This provided the necessary seed money This volume marks a step along the way to a more complete understanding of parasite genomes. Many new genes have been discovered and many now await more detailed characterization. As new technologies and funding become available the speed of data acquisition will increase enormously. There can be little doubt that the generation and efficient handling of genome data will significantly enhance our ability to understand and control parasitic diseases.
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